GD2 and Its Biosynthetic Enzyme GD3 Synthase Promote Tumorigenesis in Prostate Cancer by Regulating Cancer Stem Cell Behavior

Researchers showed that GD2 was expressed in a small subpopulation of prostate cancer cells in a subset of patients and a higher proportion of metastatic tumors.